SCHEMBL21687628

SCHEMBL21687628

N#Cc1ccc(-c2ccccc2-n2c3ccccc3c3ccccc32)cc1[Si](c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 2/20 0.34
CYP11B1 P15538 1/20 0.34
AR P10275 5/20 0.33
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TRPA1 O75762 1/20 0.33
HPGD P15428 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
HSD17B10 Q99714 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
LMNA P02545 1/20 0.33
MAPK1 P28482 1/20 0.33
ALOX5AP P20292 1/20 0.32
FEN1 P39748 1/20 0.32
HIF1A Q16665 1/20 0.32
PGR P06401 2/20 0.32
IMPDH2 P12268 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21687722 0.93 CYP11B1 (0.31) CYP11B2CYP11B1
SCHEMBL21688048 0.92 SMN1; SMN2 (0.40) CYP11B2CYP11B1ARALDH1A1TRPA1
SCHEMBL21687970 0.91 ALDH1A1 (0.33) CYP11B2CYP11B1ARALDH1A1KDM4E
SCHEMBL21687739 0.90 KDM4E (0.35) CYP11B2CYP11B1ALDH1A1KDM4EATM
SCHEMBL21687831 0.89 CYP11B1 (0.32) CYP11B2CYP11B1ALDH1A1KDM4EATM
SCHEMBL21687929 0.89 GABRA1 (0.34) CYP11B2CYP11B1ARALDH1A1ATM
SCHEMBL21687984 0.88 CYP11B2 (0.34) CYP11B2CYP11B1ARALDH1A1KDM4E
SCHEMBL21687460 0.88 ESR2 (0.35) ALDH1A1KDM4EATML3MBTL1TRPA1
SCHEMBL21688040 0.88 ALDH1A1 (0.35) CYP11B2CYP11B1ARALDH1A1KDM4E
SCHEMBL21687462 0.87 SMN1; SMN2 (0.38) ALDH1A1KDM4EATML3MBTL1TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 CYP11B2 1646/4885CYP11B1 1222/4885AR 1928/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 CYP11B2 1646/4885CYP11B1 1222/4885AR 1928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.